Synthetic oligosaccharide-protein conjugate N. meningitidis vaccine is immunogenic in vivo Sep. 2, 2019
Phase III results for V-212 inactivated varicella zoster virus vaccine in patients with malignancies Aug. 29, 2019
Immunogenicity and efficacy animal studies of a new vaccine against Lassa virus confirm protection Aug. 28, 2019
Tonix, Massachusetts General Hospital enter collaboration to develop MAb for transplant rejection Aug. 23, 2019
RSS